Notícias Eulerpool Adhera Therapeutics

Adhera Therapeutics Eulerpool-AFX

Adhera Therapeutics Notícias de ações

Adhera Therapeutics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Adhera Therapeutics nós reunimos aqui.

• 12 de fevereiro ·

  GuruFocus
  Adhera Therapeutics Inc Annual Shareholders Meeting Transcript
• 27 de novembro ·

  MarketWatch
  Biodexa Pharma Shares Double After Licensing Deal for Tolimidone
• 27 de novembro ·

  MarketWatch
  Biodexa Enters Worldwide Licensing Deal for Tolimidone
• 25 de janeiro ·

  Yahoo
  Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes
• 5 de dezembro ·

  Seeking Alpha
  Adhera Therapeutics files for Nasdaq uplisting, $35M offering
• 7 de outubro ·

  DowJones
  U.S. stocks end sharply lower after strong jobs report keeps Fed on hiking path, but post gain for week
• 3 de outubro ·

  DowJones
  Bear Market Playbook - MarketWatch
• 26 de setembro ·

  DowJones
  He ‘house hacked’ his way to wealth, and now plans to build a mansion - MarketWatch
• 23 de setembro ·

  DowJones
  Building Generational Wealth - MarketWatch
• 19 de setembro ·

  Yahoo
  Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist